marijuana stocks news

CannaVEST Corp. (CANV)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 2,693   1,860   3,006   2,632  
Cost of Revenue 1,418 738 1,210 1,021
Gross Profit 1,275   1,122   1,796   1,611  
Operating Expenses
Research Development 430 262 157 151
Selling General and Administrative 9,575 1,351 1,507 924
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (8,730) (490) 132   535  
Income from Continuing Operations
Total Other Income/Expenses Net (39)
Earnings Before Interest And Taxes (8,136) (482) 7,425 497
Interest Expense 615 (615) 615
Income Before Tax (8,752) (482) 8,040 (118)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (8,752) (482) 15,901 (118)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (8,752) (482) 8,040   (118)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (8,752) (482) 8,040   (118)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

High Park Farms™ Ltd., a subsidiary of Tilray, Inc. (TLRY) Receives Cannabis Sales License from Health Canada

High Park Farms™ Receives Cannabis Sales License from Health Canada High Park…

SNDL Inc. (SNDL) Reports Full Year and Fourth Quarter 2022 Financial and Operational Results

SNDL Reports Full Year and Fourth Quarter 2022 Financial and Operational Results…

$VHUB Opening New Luxurious Vaping Lounge in Simi Valley

Vapor Hub International Opening New Luxurious Vaping Lounge in Simi Valley SIMI…

Cara Therapeutics, Inc. (CARA) Completes Enrollment of KALM-1 Pivotal Phase 3 Trial Of KORSUVA™

Cara Therapeutics Completes Enrollment of KALM-1 Pivotal Phase 3 Trial Of KORSUVA™…